American Funds Europacific Growth R5E (RERHX) Comparison with companies in other sectors?

American Funds Europacific Growth R5E has a share price of 2.20B. You can analyze American Funds Europacific Growth R5E (RERHX) competitors across different market sectors through stock heatmaps.

What are RERHX's NET and operating margins?

American Funds Europacific Growth R5E (RERHX) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does RERHX's earnings per share (EPS) trend reflect its financial momentum?

American Funds Europacific Growth R5E (RERHX) EPS is 3.09 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for American Funds Europacific Growth R5E is 20.64, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for American Funds Europacific Growth R5E?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for American Funds Europacific Growth R5E like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

American Funds Europacific Growth R5E

RERHX•NASDAQ

Financial Services

Asset Management

$64.43

$0.46(0.72%)

U.S. Market is Open • 11:13

American Funds Europacific Growth R5E Fundamental Analysis

American Funds Europacific Growth R5E (RERHX) shows weak financial fundamentals with a PE ratio of 20.64, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze RERHX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze RERHX's fundamental strength across five key dimensions:

Efficiency Score

Weak

RERHX struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

RERHX shows balanced valuation metrics.

PE < 25

20.64

PEG Ratio < 2

N/A

Growth Score

Moderate

RERHX shows steady but slowing expansion.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

RERHX carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

RERHX struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is RERHX Expensive or Cheap?

P/E Ratio

RERHX trades at 20.64 times earnings. This indicates a fair valuation.

20.64

How Well Does RERHX Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How RERHX Stacks Against Its Sector Peers

Metric	RERHX Value	Sector Average	Performance
P/E Ratio	N/A	18.86	N/A
ROE	N/A	847.00%	N/A
Net Margin	N/A	4202.00%	N/A
Debt/Equity	N/A	0.91	N/A
Current Ratio	N/A	667.17	N/A
ROA	N/A	-21543.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews American Funds Europacific Growth R5E's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

American Funds Europacific Growth R5E Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is RERHX Expensive or Cheap?

How Well Does RERHX Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How RERHX Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

American Funds Europacific Growth R5E (RERHX) Comparison with companies in other sectors?

What are RERHX's NET and operating margins?

In what way does RERHX's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for American Funds Europacific Growth R5E?

How do I know if AAPL is overvalued or undervalued?